Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Looking for participantsNCT07206498What this trial is testingEvaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLCWho this might be right forNon Small Cell Lung Cancer (NSCLC) Wayshine Biopharm, Inc. 48
Early research (Phase 1)Looking for participantsNCT05452005What this trial is testingFluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung CancerWho this might be right forLung CancerLung Cancer MetastaticBrain Metastases+1 more University of California, Davis 20
Testing effectiveness (Phase 2)Study completedNCT00831545What this trial is testingStudy to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)Who this might be right forMetastases of Central Nervous SystemMelanomaBreast Neoplasm+1 more Merck Sharp & Dohme LLC 162
Large-scale testing (Phase 3)UnknownNCT03732482What this trial is testingTemozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain MetastasesWho this might be right forNon Small Cell Lung Cancer Metastatic Taizhou Hospital 400
Testing effectiveness (Phase 2)Ended earlyNCT00034697What this trial is testingStudy of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)Who this might be right forMetastases, NeoplasmCarcinoma, Non-Small-Cell LungBrain Neoplasms Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Looking for participantsNCT07132190What this trial is testingStereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin ReductionWho this might be right forBrain Metastases, AdultBrain Tumor - MetastaticBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+1 more Ayal A. Aizer, MD 60
Testing effectiveness (Phase 2)Study completedNCT05865990What this trial is testingHER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal DiseaseWho this might be right forMetastatic Breast CancerAdvanced Non-Small Cell Squamous Lung CancerSolid Tumor, Adult MedSIR 63
Large-scale testing (Phase 3)Study completedNCT01951482What this trial is testingPemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung CancerWho this might be right forNon Squamous Non-small Cell Lung CancerBrain MetastasesBevacizumab Sun Yat-sen University 160
Large-scale testing (Phase 3)Study completedNCT00377156What this trial is testingStereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesWho this might be right forBreast CancerCognitive/Functional EffectsLung Cancer+2 more Alliance for Clinical Trials in Oncology 213
Testing effectiveness (Phase 2)Looking for participantsNCT07535463What this trial is testingIvonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 53
Not applicableUnknownNCT06014450What this trial is testingProphylactic Cranial Irradiation Versus Observation in Stage IV NSCLC Randomized Controlled Clinical StudyWho this might be right forProphylactic Cranial Irradiation, Cumulative Incidence of Brain Metastases Guizhou Medical University 144
Testing effectiveness (Phase 2)Study completedNCT02308020What this trial is testingAbemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainWho this might be right forBreast CancerNon-small Cell Lung CancerMelanoma+1 more Eli Lilly and Company 162
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365410What this trial is testingFurmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety StudyWho this might be right forNon-small Cell Lung Cancer (NSCLC)Brain MetastasesFurmonertinib+1 more Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00219297What this trial is testingStudy of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung CancerWho this might be right forBrain MetastasisNon-small Cell Lung Cancer Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07413952What this trial is testingLimertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain MetastasesWho this might be right forNSCLC The First Affiliated Hospital of Guangzhou Medical University 45
Testing effectiveness (Phase 2)Ended earlyNCT04964960What this trial is testingPembro+Chemo in Brain MetsWho this might be right forLung CancerLung Cancer MetastaticBrain Cancer+1 more John L. Villano, MD, PhD 3
Not applicableNot Yet RecruitingNCT06716775What this trial is testingTumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.Who this might be right forNSCLC Brain Metastasis Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 200
Testing effectiveness (Phase 2)Study completedNCT04507217What this trial is testingTislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLCWho this might be right forNSCLC Stage IVBrain MetastasesPD-1 Antibody Sun Yat-sen University 36
Large-scale testing (Phase 3)Study completedNCT00390806What this trial is testingOral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung CancerWho this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 472